Clinical trial
Maintenance Treatment Versus Observation After Induction in Advanced Colorectal…
NCT00442637 · Dutch Colorectal Cancer Group, Other · Unknown status
Key facts
| NCT number | NCT00442637 |
|---|---|
| Title | Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma |
| Official title | Maintenance Treatment With Capecitabine and Bevacizumab Versus Observation After Induction Treatment With Chemotherapy and Bevacizumab as First-line Treatment in Patients With Advanced Colorectal Carcinoma |
| Acronym | CAIRO3 |
| Lead sponsor | Dutch Colorectal Cancer Group, Other |
| Collaborators | Koningin Wilhelmina Fonds Sanofi Industry Hoffmann-La Roche |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer Metastatic |
| Intervention type | Drug, Other |
| Interventions | capecitabine + bevacizumab, observation |
| Enrollment | 635 |
| Start date | Jan 1, 2007 |
| Primary completion | Sep 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Mar 2, 2007 |
| Last update posted | Dec 12, 2013 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: